Inhibitors of protein kinases and protein phosphates /
| Other Authors: | , , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Berlin ; New York :
Springer,
[2005]
|
| Series: | Handbook of experimental pharmacology.
v. 167. |
| Subjects: |
Table of Contents:
- Protein kinase inhibitors for the treatment of disease : the promise and the problems
- Pt. I. General aspects of PKs inhibition
- New design strategies for ligands that target protein kinase-mediated protein-protein interaction
- Pt. II. Pharmacological potential and inhibitors of individual classes of protein kinases
- The paullones : a family of pharmacological inhibitors of cyclin-dependent kinases and glycogen synthase kinase 3
- Pharmacological potential of p38 MARK inhibitors
- Inhibitors of PKA and related protein kinases
- Inhibitors of protein kinase CK2 : structural aspects
- Aminoglycoside kinases and antibiotic resistance
- Pt. III. Pharmacological potential and inhibitors of individual classes of protein phosphatases
- Protein tyrosine phosphatases as therapeutic targets
- Structure-based design of protein tyrosine phsophatase inhibitors
- Biological validation of the CD45 tyrosine phosphatase as a pharmaceutical target
- Serine/threonine protein phosphatase inhibitors with antitumor activity
- Pt. IV. Inhibitors in clinical use or advanced clinical trials
- Clinical immunosuppression using the calcineurin-inhibitors ciclosporin and tacrolimus
- Targeted therapy with imatinib : an exception or a rule?
- Clinical aspects of imatinib therapy
- Isoquinolinesulfonamide : a specific inhibitor of Rho-kinase and the clinical aspect of anti-Rho-kinase therapy
- Discovery and development of Iressa : the first in a new class of drugs targeted at the epidermal growth factor tyrosine kinase